Literature DB >> 10426273

Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells.

Z Liu1, S Tugulea, R Cortesini, S Lederman, N Suciu-Foca.   

Abstract

Understanding the mechanism which underlies the induction of immunologic tolerance is crucial to the development of strategies for treatment of autoimmune diseases and allograft rejection. Although the concept that T suppressor cells (Ts) downregulate the immune response has long been accepted, the existence of a distinct population of lymphocytes that mediates suppression has not been convincingly demonstrated. In previous studies, we have utilized human T cell lines (TCLs) to analyze the suppressive effects of CD8+CD28 T cells in allogeneic, peptide specific and xeno-specific responses. In each case, CD8+CD28- T cells inhibit proliferation of CD4+ T helper lymphocytes (Th) with cognate antigen specificity. These CD8+CD28- T cells display the critical functional characteristics of T suppressor cells. Similar to the induction of CD8+ cytotoxic T cells (Tc) by Th, this process depends on antigen presenting cells (APC) acting as a "bridge" between MHC-class I specific CD8+ and class II specific CD4+ T cells. A possible explanation of Ts-mediated suppression is their ability to modulate the function of APCs. The present studies show that CD8+CD28- Ts directly inhibit the CD40 signaling pathway of APC by a contact-dependent mechanism that renders bridging APCs incapable of inducing CD4+ Th activation. The effects of Ts on the functional state of APC supports the concept that the order in which Ts and Th cells interact with cognate APCs determines the functional outcome of immune responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426273     DOI: 10.1016/s0198-8859(99)00044-0

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

Review 1.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

2.  Regulatory functions of CD8+CD28- T cells in an autoimmune disease model.

Authors:  Nader Najafian; Tanuja Chitnis; Alan D Salama; Bing Zhu; Christina Benou; Xueli Yuan; Michael R Clarkson; Mohamed H Sayegh; Samia J Khoury
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 3.  Regulatory immune cells in transplantation.

Authors:  Kathryn J Wood; Andrew Bushell; Joanna Hester
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

4.  The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand.

Authors:  Hava Ben-David; Amir Sharabi; Molly Dayan; Michael Sela; Edna Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

5.  Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells.

Authors:  Michel Gilliet; Yong-Jun Liu
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

Review 6.  Female Unexplained Infertility: A Disease with Imbalanced Adaptive Immunity.

Authors:  Motahareh Ehsani; Mousa Mohammadnia-Afrouzi; Mohammad Mirzakhani; Sedighe Esmaeilzadeh; Mehdi Shahbazi
Journal:  J Hum Reprod Sci       Date:  2019-12-17

7.  Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice.

Authors:  George Vlad; Vivette D D'Agati; Qing-Yin Zhang; Zhuoru Liu; Eric K Ho; Thalachallour Mohanakumar; Mark A Hardy; Raffaello Cortesini; Nicole Suciu-Foca
Journal:  Diabetes       Date:  2008-04-16       Impact factor: 9.461

Review 8.  Molecular and Cellular Characterization of Human CD8 T Suppressor Cells.

Authors:  Zheng Xu; Sophey Ho; Chih-Chao Chang; Qing-Yin Zhang; Elena-Rodica Vasilescu; George Vlad; Nicole Suciu-Foca
Journal:  Front Immunol       Date:  2016-11-30       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.